Galapagos | GLPG - Market Capitalization

Stock Price
29.37
Daily Change
0.21 0.72%
Monthly
7.58%
Yearly
34.36%
Q1 Forecast
27.75

Galapagos reported EUR1.93B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
argenx SE USD 44.32B 15.63B Sep/2025
AstraZeneca USD 233.07B 17.56B Sep/2025
Biogen USD 20.54B 2.13B Sep/2025
Genmab DKK 80.88B 7.82B Jun/2025
Gilead Sciences USD 137.73B 184M Sep/2025
GlaxoSmithKline GBP 64.04B 7.8B Sep/2025
GRIFOLS EUR 7.49B 1.16B Sep/2025
Hikma Pharmaceutical USD 6.06B 1.64B Jun/2025
Incyte USD 16.56B 3.38B Sep/2025
Merck EUR 47.59B 239.13M Sep/2025
Neurocrine Biosciences USD 13.92B 1.48B Sep/2025
Novartis USD 265.66B 9.48B Sep/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
UCB EUR 32.47B 4.91B Jun/2025
Vertex Pharmaceuticals USD 100.41B 13.91B Sep/2025